WallStSmart
ALT

Altimmune Inc

NASDAQ: ALT · HEALTHCARE · BIOTECHNOLOGY

$2.60
-1.14% today

Updated 2026-04-30

Market cap
$511.15M
P/E ratio
P/S ratio
12,467.17x
EPS (TTM)
$-1.00
Dividend yield
52W range
$3 – $8
Volume
4.1M

Altimmune Inc (ALT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$1.85M$14.64M$32.91M$27.55M$20.99M$24.27M$25.18M$17.91M$10.19M$10.64M$5.23M$41503.00$10.33M$5.80M$8.19M$4.41M$-68000.00$426000.00$20000.00$41000.00
Revenue growth (YoY)+692.5%+124.7%-16.3%-23.8%+15.6%+3.7%-28.9%-43.1%+4.4%-50.8%-99.2%+24792.6%-43.8%+41.1%-46.1%-101.5%+726.5%-95.3%+105.0%
Cost of revenue$0.00$0.00$0.00$4.27M$5.06M$7.22M$18.41M$18.46M$17.07M$33.51M$73.84M$500000.00$477000.00$238000.00$112000.00
Gross profit$1.85M$14.64M$32.91M$27.55M$20.99M$24.27M$25.18M$17.91M$5.93M$5.58M$-1.99M$-18.36M$-8.13M$5.80M$-25.32M$4.41M$-68000.00$426000.00$20000.00$-71000.00
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%58.1%52.4%-38.1%-44249.4%-78.7%100.0%-309.4%100.0%100.0%100.0%100.0%-173.2%
R&D$16.56M$31.81M$30.22M$20.88M$21.22M$19.51M$15.29M$9.32M$5.13M$4.84M$18.41M$18.46M$17.77M$49.77M$74.54M$70.54M$65.80M$82.23M$66.43M
SG&A$491093.00$13.88M$19.40M$22.43M$18.02M$14.31M$11.63M$13.28M$10.91M$6.22M$11.52M$8.46M$9.77M$8.50M$13.21M$15.41M$17.13M$18.14M$20.97M$28.10M
Operating income$1.20M$-16.50M$-35.24M$-25.97M$-23.55M$-11.73M$-6.27M$-10.84M$-10.19M$-3.40M$-11.26M$-52.05M$-42.83M$-21.46M$-54.80M$-96.91M$-87.74M$-95.93M$-103.17M$-94.49M
Operating margin65.1%-112.7%-107.1%-94.3%-112.2%-48.3%-24.9%-60.5%-100.0%-32.0%-215.4%-125401.2%-414.6%-370.0%-669.5%-2197.6%129029.4%-22518.5%-515860.0%-230461.0%
EBITDA$1.20M$-15.80M$-33.03M$-28.57M$-23.26M$-3.28M$-4.08M$-11.10M$-9.53M$-3.18M$-10.91M$-51.76M$-44.72M$-20.19M$-38.10M$-96.53M$-84.41M$-87.94M$-94.81M$-94.49M
EBITDA margin65.1%-107.9%-100.4%-103.7%-110.8%-13.5%-16.2%-62.0%-93.5%-29.9%-208.7%-124720.2%-432.9%-348.0%-465.5%-2189.0%124130.9%-20642.0%-474060.0%-230461.0%
EBIT$1.20M$-16.45M$-33.84M$-29.44M$-24.28M$-3.74M$-4.38M$-11.29M$-9.68M$-3.32M$-11.05M$-51.90M$-45.02M$-20.58M$-38.53M$-97.08M$-84.90M$-88.41M$-95.05M$-94.60M
Interest expense$0.00$2.12M$2.57M$2.84M$5.94M$54573.00$342561.00$369281.00$210399.00$54581.00$38499.00$162139.00$297090.00$2244.00$9421.00$5000.00$8000.00$35000.00$9000.00$1.64M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$1.02M$-13.59M$-36.42M$-32.28M$-34.85M$-3.80M$-4.92M$-11.72M$-9.96M$-3.44M$193.85M$-46.43M$-39.17M$-20.52M$-49.04M$-97.09M$-84.71M$-88.45M$-95.06M$-88.09M
Net income growth (YoY)-1436.9%-168.0%+11.4%-8.0%+89.1%-29.6%-138.2%+15.0%+65.4%+5734.1%-123.9%+15.6%+47.6%-139.0%-98.0%+12.7%-4.4%-7.5%+7.3%
Profit margin55.0%-92.8%-110.6%-117.2%-166.0%-15.6%-19.5%-65.4%-97.7%-32.3%3706.4%-111860.3%-379.2%-353.7%-599.2%-2201.6%124577.9%-20762.2%-475295.0%-214861.0%